Axa’s Cantel Medical Corporation CMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-51,709
Closed -$4.76M 1404
2018
Q3
$4.76M Buy
51,709
+642
+1% +$61.2K 0.02% 689
2018
Q2
$5.02M Buy
51,067
+22,017
+76% +$2.46M 0.02% 654
2018
Q1
$3.24M Buy
+29,050
New +$3.26M 0.01% 754
2016
Q4
Sell
-3,000
Closed -$234K 1308
2016
Q3
$234K Sell
3,000
-15,220
-84% -$1.1M ﹤0.01% 1150
2016
Q2
$1.25M Buy
+18,220
New +$1.26M 0.01% 832

Other funds holding CMD

Axa's CMD Position: Q4 2018 in Review

Axa sold out of Cantel Medical Corporation (CMD) in Q4 2018, closing a stake of 51,709 shares — an estimated $4.76M sold.

Axa first reported a position in CMD in Q2 2016 and held it in 5 quarters. The position peaked at $5.02M in Q2 2018. 253 funds tracked by Wall St. Rank hold CMD as of Q4 2018.

  • Axa reported no remaining Cantel Medical Corporation position as of Q4 2018 after selling out during the quarter.
  • Axa sold 51,709 Cantel Medical Corporation shares in Q4 2018, an estimated $4.76M.
  • Axa first reported a position in Cantel Medical Corporation in Q2 2016 and held it in 5 quarters.
  • Axa's Cantel Medical Corporation position peaked at $5.02M in Q2 2018.
  • 253 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q4 2018.

Based on Axa's 13F filing for Q4 2018, filed 13 Feb 2019.